Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-16-017084
Filing Date
2016-09-28
Accepted
2016-09-28 16:11:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROSPECTUS SUPPLEMENT f424b5092716_actinium.htm 424B5 978025
2 GRAPHIC image_001.jpg GRAPHIC 8308
  Complete submission text file 0001213900-16-017084.txt   990666
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-194768 | Film No.: 161907071
SIC: 2834 Pharmaceutical Preparations